Want to join the conversation?
$PG expects organic sales growth of about 2% for FY17. $PG estimates all-in sales growth of about 1% for FY17. The company expects core EPS growth of mid-single digits versus FY16 core EPS of $3.67. All-in GAAP EPS are expected to increase 45-55% versus FY16 GAAP EPS of $3.69.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?